What is ESSA Pharma Inc (EPIX)?

Aktienanalyse zu ESSA Pharma Inc (EPIX)

$0.201

-0.004 (-1.85%)Zum Schluss

Loading chart…

High: 0.207
Open: 0.200
VWAP: 0.20
Vol: 5.95M
Mkt Cap: 229.80M
Low: 0.190
Amount: 1.19M
EV/EBITDA, TTM: 0.00

ESSA Pharma Inc. is a Canada-based pharmaceutical company that was previously focused on developing therapies for the treatment of patients with prostate cancer. The Company is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.

www.essapharma.com

Bewertungskennzahlen

The current forward P/E ratio for ESSA Pharma Inc (EPIX) is -0.33, compared to its 5-year average forward P/E of -4.95.

Forward P/E

Overvalued

5Y Average P/E

-4.95

Current P/E

-0.33

Überbewertet

-2.07

Unterbewertet

-7.83

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-0.49

Current EV/EBITDA

0.00

Überbewertet

1.51

Unterbewertet

-2.49

Forward P/S

Fair

5Y Average P/S

1.01

Current P/S

0.00

Überbewertet

7.45

Unterbewertet

-5.43

Alphio AI Price Scenarios for EPIX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%EPIX

$2.26

Szenariopreis

Base

Base · 50%EPIX

$2.05

Szenariopreis

Bear

Bear · 25%EPIX

$1.89

Szenariopreis

Whales holding EPIX

BVF Partners L.P.

+ HoldingEPIX

+16.11%

3M Return

Event-Zeitleiste

2025-10-06 (ET)